BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26063860)

  • 1. Reducing Unnecessary and Duplicate Ordering for Ovum and Parasite Examinations and Clostridium difficile PCR in Immunocompromised Patients by Using an Alert at the Time of Request in the Order Management System.
    Otto CC; Shuptar SL; Milord P; Essick CJ; Nevrekar R; Granovsky SL; Seo SK; Babady NE; Martin SC; Tang YW; Pessin MS
    J Clin Microbiol; 2015 Aug; 53(8):2745-8. PubMed ID: 26063860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for Clostridium difficile.
    Luo RF; Spradley S; Banaei N
    J Clin Microbiol; 2013 Nov; 51(11):3872-4. PubMed ID: 23985918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?
    Sunkesula VC; Kundrapu S; Muganda C; Sethi AK; Donskey CJ
    Clin Infect Dis; 2013 Aug; 57(4):494-500. PubMed ID: 23645849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
    Catanzaro M; Cirone J
    Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
    Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
    Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.
    Deshpande A; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Pant C; Hernandez AV
    Clin Infect Dis; 2011 Oct; 53(7):e81-90. PubMed ID: 21890762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea.
    Peterson LR; Manson RU; Paule SM; Hacek DM; Robicsek A; Thomson RB; Kaul KL
    Clin Infect Dis; 2007 Nov; 45(9):1152-60. PubMed ID: 17918076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of imported Clostridium difficile PCR-ribotype 027 infection within the Czech Republic which has a high prevalence of C. difficile ribotype 176.
    Krutova M; Nyc O; Kuijper EJ; Geigerova L; Matejkova J; Bergerova T; Arvand M
    Anaerobe; 2014 Dec; 30():153-5. PubMed ID: 25300750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of polymerase chain reaction testing on Clostridium difficile infection rates in an acute health care facility.
    Murad YM; Perez J; Nokhbeh R; Ybazeta G; Dewar B; Lefebvre S; Diaz-Mitoma F
    Am J Infect Control; 2015 Apr; 43(4):383-6. PubMed ID: 25687359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
    Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
    Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of rejection criteria for stool ovum and parasite examinations.
    Morris AJ; Wilson ML; Reller LB
    J Clin Microbiol; 1992 Dec; 30(12):3213-6. PubMed ID: 1452704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.
    Baker I; Leeming JP; Reynolds R; Ibrahim I; Darley E
    J Hosp Infect; 2013 Aug; 84(4):311-5. PubMed ID: 23831282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the rapid loop-mediated isothermal amplification assay Illumigene for diagnosis of Clostridium difficile in an outbreak situation.
    Norén T; Unemo M; Magnusson C; Eiserman M; Matussek A
    APMIS; 2014 Feb; 122(2):155-60. PubMed ID: 23758095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword.
    Williamson DA; Basu I; Freeman J; Swager T; Roberts SA
    Am J Infect Control; 2013 Mar; 41(3):270-2. PubMed ID: 22939418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the diagnostic algorithm consisting of enzyme immunoassay for toxins and polymerase chain reaction, for the diagnosis of Clostridium difficile-associated diarrhoea.
    Lee JH; Park SJ; Lee YM; Lee CH; Cho JH
    Scand J Infect Dis; 2012 Dec; 44(12):969-72. PubMed ID: 22813084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and culture-based diagnosis of Clostridium difficile isolates from Côte d'Ivoire after prolonged storage at disrupted cold chain conditions.
    Becker SL; Chatigre JK; Coulibaly JT; Mertens P; Bonfoh B; Herrmann M; Kuijper EJ; N'Goran EK; Utzinger J; von Müller L
    Trans R Soc Trop Med Hyg; 2015 Oct; 109(10):660-8. PubMed ID: 26354793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interobserver variability and feasibility of polymerase chain reaction-based assay in distinguishing ischemic colitis from Clostridium difficile colitis in endoscopic mucosal biopsies.
    Wiland HO; Procop GW; Goldblum JR; Tuohy M; Rybicki L; Patil DT
    Am J Clin Pathol; 2013 Jun; 139(6):730-5. PubMed ID: 23690114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.